Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RCUS

Arcus Biosciences Inc

Dec 01 • 04:00PM ET

16.07

Dollar change +1.01
Percentage change 6.71	%

Healthcare • Biotechnology • USA • NYSE

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.00	Insider Own	35.63%	Shs Outstand	72.90M	Perf Week	14.30%
Market Cap	1.20B	Forward P/E	-	EPS next Y	-4.03	Insider Trans	3.55%	Shs Float	48.18M	Perf Month	1.58%
Income	-293.46M	PEG	-	EPS next Q	-1.02	Inst Own	65.86%	Short Float / Ratio	12.50% / 8.16	Perf Quarter	-24.20%
Sales	119.66M	P/S	10.05	EPS this Y	-8.14%	Inst Trans	-0.86%	Short Interest	6.02M	Perf Half Y	-23.51%
Book/sh	6.95	P/B	2.31	EPS next Y	-0.50%	ROA	-22.71%	Target Price	40.67	Perf Year	-54.31%
Cash/sh	10.67	P/C	1.51	EPS next 5Y	-	ROE	-48.16%	52W Range	12.95 - 36.13	Perf YTD	-22.29%
Dividend	-	P/FCF	-	EPS past 5Y	-25.04%	ROI	-56.43%	52W High	-55.52%	Beta	0.69
Dividend %	-	Quick Ratio	4.41	Sales past 5Y	262.14%	Gross Margin	87.94%	52W Low	24.09%	ATR	0.88
Employees	500	Current Ratio	4.41	Sales Q/Q	-4.71%	Oper. Margin	-270.31%	RSI (14)	58.94	Volatility	5.73% 6.08%
Optionable	Yes	Debt/Eq	0.02	EPS Q/Q	-5.90%	Profit Margin	-245.25%	Rel Volume	1.07	Prev Close	15.06
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 07 AMC	Payout	-	Avg Volume	737.41K	Price	16.07
Recom	1.50	SMA20	10.09%	SMA50	1.12%	SMA200	-12.55%	Volume	791,397	Change	6.71%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-18-22	Initiated	BofA Securities	Neutral	$33
Oct-11-22	Initiated	Morgan Stanley	Overweight	$40
Oct-15-21	Resumed	BTIG Research	Buy	$57
Nov-24-20	Initiated	Berenberg	Buy	$50
Nov-23-20	Initiated	Evercore ISI	Outperform
Apr-03-20	Initiated	Cantor Fitzgerald	Overweight	$21
Mar-04-20	Initiated	Barclays	Overweight	$24
Nov-12-19	Initiated	SunTrust	Buy	$20
Sep-27-19	Initiated	Mizuho	Buy	$22
May-24-19	Resumed	Citigroup	Buy	$25
Oct-09-18	Initiated	Wedbush	Outperform	$22
Apr-09-18	Initiated	Leerink Partners	Outperform	$21
Apr-09-18	Initiated	Goldman	Neutral	$18
Apr-09-18	Initiated	Citigroup	Buy	$18

Show Previous Ratings

Nov-27-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Nov-14-23 04:00PM	Arcus Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference (Business Wire) +7.15%
Nov-13-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Nov-08-23 04:05PM	Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 04:01PM	Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update (Business Wire) +5.65%
05:00PM	Loading…
Nov-06-23 05:00PM	Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-Line Treatment for Upper GI Cancers (Business Wire)
Oct-31-23 10:01AM	Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks) +5.08%
Oct-24-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Oct-17-23 04:00PM	Arcus Biosciences to Present Data from Ongoing EDGE-Gastric Study at ASCO Plenary and to Report Third-Quarter Financial Results on November 7 (Business Wire)
Oct-10-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Sep-27-23 05:14AM	Strength Seen in Adaptive Biotechnologies (ADPT): Can Its 9.5% Jump Turn into More Strength? (Zacks)
Sep-26-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Sep-11-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Sep-05-23 07:37PM	Arcus Biosciences (RCUS): A Modestly Undervalued Gem? (GuruFocus.com)
Aug-24-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
11:30AM	Loading…
11:30AM	Biotech Stocks Rally After Roche's (RHHBY) Accidental Data Leak (Zacks)
09:02AM	Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study (Zacks)
Aug-23-23 11:39AM	Arcus Biosciences: A Modestly Undervalued Opportunity? (GuruFocus.com) +22.43%
09:00AM	Arcus Biosciences to Participate in Multiple Upcoming Investor Conferences (Business Wire)
Aug-09-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Aug-07-23 09:15AM	Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update (Business Wire)
Aug-03-23 05:55PM	Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-02-23 05:25PM	Allogene Therapeutics (ALLO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-01-23 05:45PM	Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-25-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Jul-11-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Jul-03-23 06:50AM	Daily Vickers Top Buyers & Sellers for 07/03/2023 (Argus Research)
Jun-26-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Jun-21-23 08:00PM	RCUS: Rating increased to a HOLD (Argus Research)
12:08PM	Loading…
Jun-12-23 12:08PM	We're Not Very Worried About Arcus Biosciences' (NYSE:RCUS) Cash Burn Rate (Simply Wall St.)
Jun-09-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Jun-05-23 02:59PM	Gilead (GILD), Arcus Announce Results From Mid-Stage NSCLC Study (Zacks)
Jun-03-23 01:30PM	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study (Business Wire)
May-30-23 04:00PM	Arcus Biosciences to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference (Business Wire) -8.03%
May-26-23 04:05PM	Arcus, Iteos Soar On Roche's 'Meaningful' Results In A New Cancer Drug Class (Investor's Business Daily) +25.89%
10:27AM	Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class (Investor's Business Daily)
May-24-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
May-17-23 08:30AM	Presentations at the 2023 ASCO Annual Meeting Highlight Arcus Biosciences Expanding Portfolio of Investigational Medicines and Late-Stage Studies Across Multiple Types of Cancer (Business Wire)
May-16-23 11:51AM	The past three years for Arcus Biosciences (NYSE:RCUS) investors has not been profitable (Simply Wall St.) -6.30%
09:31AM	Arcus (RCUS) & Gilead Re-Collaborate for Inflammatory Diseases (Zacks)
May-15-23 08:30AM	Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation (Business Wire) +5.63%
May-11-23 09:44AM	Reata (RETA) Q1 Earnings Miss, Stock Dips on Pipeline Updates (Zacks)
09:33AM	TEVA Q1 Earnings Miss Estimates, Sales Beat, Stock Declines (Zacks)
07:44AM	Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Grow (Zacks)
May-09-23 06:15PM	Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update (Business Wire)
May-08-23 04:35PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
10:04AM	Intra-Cellular (ITCI) Q1 Earnings Top, Caplyta Volume Rises (Zacks)
May-05-23 12:45PM	Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Rise Y/Y (Zacks)
09:17AM	Apellis (APLS) Q1 Earnings Miss, Empaveli & Syfovre Fuel Growth (Zacks)
May-04-23 12:04PM	Zoetis (ZTS) Q1 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks) +5.01%
May-03-23 01:47PM	Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall (Zacks)
01:20PM	Repligen (RGEN) Beats on Q1 Earnings, Lowers 2023 Guidance (Zacks)
May-01-23 10:00AM	Earnings Preview: Arcus Biosciences, Inc. (RCUS) Q1 Earnings Expected to Decline (Zacks)
Apr-26-23 08:00PM	RCUS: Lowering target price to $14.00 (Argus Research)
Apr-25-23 04:05PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Apr-19-23 11:17AM	Getting In Cheap On Arcus Biosciences, Inc. (NYSE:RCUS) Is Unlikely (Simply Wall St.)
Apr-11-23 04:05PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Mar-09-23 04:05PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire) -6.75%
Mar-06-23 12:33PM	KALA Q4 Loss Wider Than Expected, Pipeline Remains in Focus (Zacks)
Mar-03-23 02:20PM	Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top (Zacks)
Mar-02-23 04:00PM	Arcus Biosciences to Participate in the Barclays Global Healthcare Conference (Business Wire)
Feb-28-23 05:35PM	Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update (Business Wire)
Feb-24-23 04:05PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Feb-23-23 01:41PM	Repligen's (RGEN) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-17-23 12:24PM	Alkermes (ALKS) Q4 Earnings & Sales Top Estimates, Stock Up (Zacks) +5.23%
Feb-15-23 10:57AM	Biogen (BIIB) Beats Q4 Earnings & Sales Estimates, Stock Up (Zacks)
07:50AM	Zacks.com featured highlights include Arcus Biosciences, Suzano and Arch Resources (Zacks)
Feb-14-23 06:33AM	Buy 3 Top Profitable Stocks Using Net Income Ratio (Zacks)
Feb-09-23 04:05PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
09:48AM	CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-08-23 10:53AM	Vertex (VRTX) Beats on Q4 Earnings & Sales, '23 View Encouraging (Zacks)
Feb-07-23 12:17PM	Will AbbVie's (ABBV) New Drugs Continue to Drive Q4 Earnings? (Zacks)
Feb-06-23 04:05PM	Arcus Biosciences to Participate at Upcoming Virtual Investor Events (Business Wire)
Feb-03-23 02:02PM	Vertex (VRTX) to Report Q4 Earnings: What's in the Cards? (Zacks)
Jan-30-23 10:00AM	GSK Gears Up to Report Q4 Earnings: What's in the Cards? (Zacks)
Jan-25-23 10:21AM	Pliant Therapeutics (PLRX) Surges 44% in A Week: Here's Why (Zacks)
Jan-24-23 04:05PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Jan-23-23 11:01AM	Amarin Corporation (AMRN) Down 13% in One Week: Here's Why (Zacks)
Jan-20-23 07:34AM	Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication (Zacks)
Jan-18-23 12:45PM	Angion (ANGN) Down on Merger Agreement With Private Biotech (Zacks)
Jan-12-23 12:38PM	Roche (RHHBY) Gets EU Approval for Xofluza in New Patient Base (Zacks)
09:35AM	Down -45.21% in 4 Weeks, Here's Why Arcus Biosciences, Inc. (RCUS) Looks Ripe for a Turnaround (Zacks)
Jan-10-23 04:05PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Dec-23-22 08:00PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Dec-22-22 08:07AM	Biotech Stock Roundup: MDGL Surges on NASH Data, TRDA, RCUS Down on Updates & More (Zacks)
Dec-20-22 04:07PM	Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche (Investor's Business Daily) -32.51%
09:56AM	Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients (Benzinga)
08:47AM	Arcus Biosciences, Gilead shares are down after sharing data about new lung cancer drug (MarketWatch)
Dec-19-22 05:00PM	Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study (Business Wire)
Dec-09-22 04:05PM	Arcus Biosciences Announces New Employment Inducement Grants (Business Wire)
Dec-02-22 10:03AM	Has Arcus Biosciences, Inc.'s (NYSE:RCUS) Impressive Stock Performance Got Anything to Do With Its Fundamentals? (Simply Wall St.)
Nov-29-22 10:14AM	Gilead (GILD), RCUS Announce Positive Data From NSCLC Study (Zacks) +6.57%
09:55AM	Wall Street Analysts Believe Arcus Biosciences, Inc. (RCUS) Could Rally 45%: Here's is How to Trade (Zacks)
Nov-28-22 04:14PM	Gilead's Cancer Program Notches Another Win, But It's Arcus Stock That Surges (Investor's Business Daily) +7.19%
11:18AM	Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures (Benzinga)
08:30AM	Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-Small Cell Lung Cancer (Business Wire)
Nov-14-22 04:05PM	Arcus Biosciences to Participate in the 5th Annual Evercore ISI HealthCONx Conference (Business Wire)

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jarrett Jennifer	Chief Operating Officer	Sep 22	Sale	19.99	21,369	427,166	302,691	Sep 26 04:35 PM
Jarrett Jennifer	Chief Operating Officer	Jul 28	Sale	20.25	45,000	911,250	336,566	Jul 31 04:15 PM
Azoy Alexander	Chief Accounting Officer	Jul 03	Sale	20.41	1,018	20,777	11,596	Jul 05 04:05 PM
GILEAD SCIENCES, INC.	10% Owner	Jun 28	Buy	19.26	1,010,000	19,452,600	14,823,029	Jun 30 03:12 PM
Jarrett Jennifer	Chief Operating Officer	Jun 22	Sale	19.12	12,437	237,795	381,566	Jun 26 04:36 PM
Jarrett Jennifer	Chief Operating Officer	Jun 16	Sale	19.35	12,563	243,094	394,003	Jun 16 08:16 PM
Goeltz II Robert C.	Chief Financial Officer	Jun 07	Sale	20.04	4,049	81,142	59,392	Jun 09 04:05 PM
Jarrett Jennifer	Chief Operating Officer	Mar 16	Sale	16.81	8,729	146,734	406,217	Mar 20 04:12 PM
Jarrett Jennifer	Chief Operating Officer	Jan 27	Sale	23.52	1,600	37,632	414,946	Jan 30 05:04 PM
Jarrett Jennifer	Chief Operating Officer	Jan 26	Sale	23.56	300	7,068	416,546	Jan 30 05:04 PM
Jarrett Jennifer	Chief Operating Officer	Dec 16	Sale	30.75	16,482	506,822	147,609	Dec 16 09:41 PM
ROSEN TERRY J	Chief Executive Officer	Dec 16	Sale	30.75	13,043	401,073	242,173	Dec 16 09:39 PM
Jaen Juan C.	President	Dec 16	Sale	30.75	4,436	136,407	218,258	Dec 16 09:40 PM
Tang Carolyn C.	General Counsel	Dec 16	Sale	30.75	2,523	77,582	28,584	Dec 16 09:42 PM
Goeltz II Robert C.	Chief Financial Officer	Dec 16	Sale	30.75	2,453	75,430	11,566	Dec 16 09:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RCUS

Arcus Biosciences Inc

Upgrade your FINVIZ experience